Charak Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Charak Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $938.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Charak Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $938.8K Trade | TransData Nexus

Charak Pharma Private Limited

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $938.8K Total Trade · DGFT Verified

Charak Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $938.8K across 2 products in 1 therapeutic categories. Based on 67 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ayurvedic ($619.3K), Herbal ($319.5K), .

Charak Pharma Private Limited — Export Portfolio & Destination Treemap

Charak Pharma Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Charak Pharma Private Limited? — Company Overview & Market Position

Charak Pharma Private Limited, established on June 8, 2000, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24230MH2000PTC127072. As of the latest available data, Charak Pharma has an authorized capital of ₹71 million and a paid-up capital of ₹68.76 million. The company is classified as a non-government entity limited by shares.

Charak Pharma specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, with a focus on Ayurvedic and herbal products. The company has a significant presence in the Indian market, with many of its brands being category leaders. Internationally, Charak Pharma exports its products to various countries across continents, including Russia, Ukraine, Kazakhstan, Kenya, South Africa, Sri Lanka, Malaysia, Greece, Bulgaria, Portugal, the Netherlands, and the USA. The company's commitment to quality is affirmed through stringent quality checks and clinical studies, and its manufacturing facilities have been awarded the WHO-GMP certification.

What Does Charak Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ayurvedic$619.3K

Product Portfolio — Top 2 by Export Value

Charak Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ayurvedic	Ayurvedic & Herbal Products	$619.3K	37	2.7%	10
2	Herbal	Ayurvedic & Herbal Products	$319.5K	30	1.7%	14

Charak Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $938.8K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Charak Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Charak Pharma operates manufacturing facilities in Mumbai, Maharashtra, India. The company's manufacturing plant is located at Evergreen Industrial Estate, Dr. E Moses Road, Shakti Mills Lane, Mahalaxmi, Mumbai, Maharashtra 400011. The facilities are equipped to produce a range of pharmaceutical formulations, including tablets, capsules, syrups, and injections, with a specialization in Ayurvedic and herbal products. The manufacturing processes adhere to stringent quality standards, and the facilities have been awarded the WHO-GMP certification, ensuring compliance with international quality norms.

3Key Leadership

Charak Pharma's leadership team comprises several key individuals:

Nimish Shroff Kishor: Director since June 8, 2000.
Vikram Shroff Kishor: Director since June 8, 2000.
Pulin Shroff Harshad: Managing Director since June 8, 2000.
Ram Hemant Shroff: Director since June 8, 2000.
Raj Hemant Shroff: Whole-Time Director since June 8, 2000.
Murali Ganapathi Kizhakkenchery: Company Secretary since March 30, 2017.

These individuals have been instrumental in steering the company towards its current position in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Charak Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Charak Pharma has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's products are manufactured in compliance with international quality standards, and its facilities have been awarded the WHO-GMP certification, which is recognized by regulatory authorities in these regions. This certification ensures that Charak Pharma's manufacturing processes meet the stringent requirements set by global health authorities.

2Emerging Markets

Charak Pharma has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's commitment to quality and efficacy has facilitated its entry into these regions, where there is a growing demand for herbal and Ayurvedic products. The WHO-GMP certification of Charak Pharma's manufacturing facilities enhances its credibility and acceptance in these markets, enabling the company to meet the regulatory requirements and consumer expectations in these regions.

3Geographic Strategy

Charak Pharma's geographic strategy involves a balanced approach between domestic leadership and international expansion. While the company holds a strong position in the Indian market, with many of its brands being category leaders, it has also made significant inroads into international markets across continents. This diversification strategy mitigates concentration risk and positions the company for sustained growth in both established and emerging markets.

Charak Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of the latest available data, there is no specific information regarding Charak Pharma's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. The company's manufacturing facilities are WHO-GMP certified, which may facilitate market access in the United States. However, for detailed FDA approvals and registrations, further information would be required.

2WHO & EU GMP

Charak Pharma's manufacturing facilities have been awarded the WHO-GMP certification, ensuring compliance with international quality standards. This certification is recognized by regulatory authorities in various regions, including the European Union, facilitating market access and acceptance of Charak Pharma's products in these markets.

3CDSCO & Indian Regulatory

Charak Pharma operates in compliance with the regulations set by the Central Drugs Standard Control Organisation (CDSCO) in India. The company's manufacturing facilities adhere to the standards prescribed by CDSCO, ensuring the safety, efficacy, and quality of its pharmaceutical products. Specific details regarding CDSCO manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) are not available in the provided information.

Charak Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Charak Pharma operates in the competitive Ayurvedic and herbal pharmaceutical market, both domestically and internationally. In India, the company faces competition from other established players in the herbal and Ayurvedic segment. Internationally, Charak Pharma competes with global pharmaceutical companies offering similar products. The company's WHO-GMP certification and commitment to quality provide a competitive edge in both domestic and international markets.

2Key Differentiators

Charak Pharma's key differentiators include its extensive experience in the Ayurvedic and herbal pharmaceutical sector, a diverse product portfolio with over 50 herbal supplements, and a strong commitment to quality, as evidenced by its WHO-GMP certification. The company's focus on converting traditional herbal knowledge into modern standardized products with scientifically proven efficacy and safety sets it apart in the market.

3Strategic Position

Charak Pharma's current strategic direction focuses on expanding its presence in both domestic and international markets, leveraging its expertise in Ayurvedic and herbal pharmaceuticals. The company's WHO-GMP certification and commitment to quality position it well for future growth and market penetration. Future outlook includes further diversification of its product portfolio and exploration of new markets to sustain growth and competitiveness.

Buyer Due Diligence Brief — Evaluating Charak Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Charak Pharma has a track record of consistent export performance, with a total export value of $939K USD across 67 shipments, indicating reliability in fulfilling international orders. The company's adherence to international quality standards, as evidenced by its WHO-GMP certification, further underscores its reliability as a supplier. However, specific details regarding export volume consistency and other reliability indicators are not available in the provided information.

2Certifications to Verify

Importers should verify the following certifications when considering Charak Pharma as a supplier:

WHO-GMP Certification: Ensures compliance with international quality standards. Verification can be done by requesting a copy of the certificate from Charak Pharma or checking with the World Health Organization.

ISO Certification: Affirms adherence to quality management standards. Verification can be done by requesting a copy of the certificate from Charak Pharma or checking with the International Organization for Standardization.

Frequently Asked Questions — Charak Pharma Private Limited

How many pharmaceutical products does Charak Pharma Private Limited export from India?

Charak Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Ayurvedic ($619.3K), Herbal ($319.5K). Total export value is $938.8K.

What is Charak Pharma Private Limited's total pharmaceutical export value?

Charak Pharma Private Limited's total pharmaceutical export value is $938.8K, based on 67 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Charak Pharma Private Limited cover?

Charak Pharma Private Limited exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Charak Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.